BenevolentAI

Life science intelligence at your fingertips

London, United Kingdom · Founded 2013 · $115.0M raised

Headquarters
London
Employees
201–500
Founded
2013
Business Model
B2B
Total Funding
$115.0M
Last Round
$115.0M Venture RoundApr 2018
Rounds
1

About

BenevolentAI is a clinical-stage, AI-enabled drug discovery and development company listed on Euronext Amsterdam. Founded in 2013, the company uses its proprietary Benevolent Platform — built on a decade of investment in knowledge graphs and ontologies — to integrate life science data and augment scientific decision-making. Headquartered in London with offices in Cambridge and New York, BenevolentAI partners with pharmaceutical companies and pursues its own pipeline for complex diseases.

Summary

BenevolentAI is a Drug Discovery company based in London, United Kingdom, founded in 2013. It has raised $115.0M in total across 1 round, most recently a $115.0M Venture Round round in Apr 2018. Investors include Woodford Investment Management.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundApr 2018
$115.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BenevolentAI on Indexed.vc
<a href="https://indexed.vc/companies/benevolentai"><img src="https://indexed.vc/api/badge/company/benevolentai" alt="BenevolentAI on Indexed.vc" width="260" height="76" /></a>